Effectiveness of rituximab in treating immune-checkpoint-inhibitor-induced immune-related adverse events: results of a systematic review
Spyros Deftereos, Dimitra Georgonikou
Topics & Concepts
MedicineAdverse effectImmune systemRituximabExacerbationContext (archaeology)ImmunologyOfatumumabCD80AntibodyPharmacologyCytotoxic T cellCD40In vitroPaleontologyBiologyChemistryBiochemistryCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology Research